register

News & Trends - MedTech & Diagnostics

Northern Sydney Cancer Centre partners with Sun Nuclear as newest reference site for radiation oncology

Health Industry Hub | March 24, 2021 |

MedTech News: Sun Nuclear Corporation, part of Mirion Technologies, announced that Australia’s Northern Sydney Cancer Centre (NSCC) is now a reference site for the SunCHECK Quality Management Platform. The centre joins leading clinics worldwide already in the reference site program.

Globally, SunCHECK technology is used by more than 1,000 users in nearly 60 countries – for integrated, automated and independent Quality Assurance in Radiation Therapy.

The NSCC treats more than 1,400 patients annually, using three Varian Medical Systems linear accelerators and a robust auto-planning program. The NSCC also uses an Elekta brachytherapy system.

In partnering with Sun Nuclear, the NSCC will support development of best practices for research and clinical use, advise on ongoing platform development, and serve as a regional resource for a rapidly-growing community of SunCHECK users. The NSCC is an integrated cancer care network, provided by the Northern Sydney Local Health District (NSLHD).

Jeremy Booth, Head of Medical Physics for the NSCC, stated that the centre is a pioneer in advanced treatments, initiating its IMRT program in 2001 and its SBRT program in 2007. Today, the NSCC remains focused on continually investigating the feasibility of technological changes, including motion management.   

“As a busy clinic with an active research program, we need an efficient, proven quality assurance mechanism,” said Booth. “SunCHECK provides the comprehensive functionality and departmental integration we were looking for and offers the efficiency our workload demands.”  

The SunCHECK Platform automates and integrates Quality Management, enabling Radiation Therapy departments to standardize Patient and Machine Quality Assurance (QA) workflows among staff, machines, and locations. A secure, browser-based network architecture connects multiple systems and can support different geographic locations, offering a top-down view through a single dashboard, supported by a single database.

SunCHECK Patient software incorporates Plan Checks, Secondary Calculations, Pre-Treatment QA and In-Vivo Monitoring all in a single workflow. SunCHECK Machine software integrates all Machine QA needs, including Daily, Monthly, and Annual QA; automated imaging, MLC and VMAT QA; and data trending. Plus, device integration with the Daily QA 3, IC PROFILER and ArcCHECK arrays enables further automation and centralization of data.


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.